ICV Value = 72.57
ISSN: 2643-6051
Research and Reviews of Infectious Diseases is an open access, peer reviewed journal publishes high quality manuscripts focusing prevention, diagnosis and treatment of disorders caused by organisms such as bacteria, viruses, fungi or parasites. The journal focus upon gathering disease types, causes, prevention, and treatment, and helps learn how they spread. The journal aims to bring multiple internationally peer reviewed experts under one roof thereby encouraging knowledge sharing, collaboration and promotion of multidisciplinary science.
All the published content is permitted to use under Creative Common Attribution License. The journal publishes topics ranging from clinical descriptions of infections, epidemics, pandemics, outbreak of contagious diseases, public health, microbiology, and immunology to the prevention of infection, the evaluation of current and novel treatments, and the promotion of optimal practices for diagnosis and treatment.
The journal invites original research, review articles, case reports, case series, short communications, opinions, short note and perspectives in the field of infectious diseases.
Professor
Boonshoft School of Medicine
Wright State University
United States of America
Tel: 937-760-7205
Professor
Department of Biology
The University of Texas at San Antonio
United States of America
Tel: 210-458-5663
Director and Associate Profressor
Department of Internal Medicine
Albert Einstein College of Medicine
New York
United States of America
Professor and Director Haskins Laboratories
Pace University
New York
United States of America
Tel: 212-346-1853
Professor
Department of Mathematics
Konkuk University
South Korea
Tel: 010-9973-4163
Professor
Department of Biological Science
Sungkyunkwan University
Suwon City, Korea
Tel: +82-31-290-7002
Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct
Case Report
A Rare Presentation of Vibrio Fluvialis
Pneumonia can be caused by a multitude of pathogens commonly associated with different environments and geographic locations. Due to a variety of fact... Read more
Review Article
Mycobacterium Tuberculosis Drug Resistance Mechanisms
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB). It affects mainly the lungs, but it may also occur in extrapulm... Read more
Research Article
Identifying Potential Hurdles to Adequate HIV Treatment Adherence, Santo André/SP, Brazil
Overcoming potential limitations for retention can improve the health of people living with HIV and favor epidemic control (Undetectable=Untransmittab... Read more
Case Report
Sudden Vision Loss: More than Just an Ophthalmic Diagnosis! A Case Report
Tuberculosis is a public health concern worldwide with India being the highest (26%). However, tuberculosis of paranasal sinuses was unusual even in c... Read more
Review Article
The Immune Response in Post-Acute COVID-19 Syndrome
Hyper-inflammation caused by COVID-19 is related to worsening of symptoms and, probably, to development of Postacute COVID-19 Syndrome, whose probable... Read more
Case Study
Tuberculosis Meningitis in Immunocompromised Patient on Rituximab
A 66-year-old patient of asian background from the US was admitted with confusion and behavioral changes for the last 10 days. The patient was on ritu... Read more
Case Study
Effective Treatment against SARS-Cov-2 with Amantadine Hydrochloride
Based on 100 documented cases treated with amantadine, we suggest that with this method of treatment, at least 90% of severe cases in Poland (or even ... Read more
Research Article
It is shown that in the conditions of the metropolis young age, early sexual life, the presence of premarital sexual experience, as well as a low leve... Read more
Mini Review
Coronavirus disease (COVID-19) pandemic currently 189.921.964 confirmed cases world wide; 4.088.281 continues with the case resulting in death. SARS-C... Read more
Review Article
Quality of Life for Patients Recovered from Covid-19
86 patients were included (70.9% women and 29.1% men), mean age 37.69. COVID-19 infection begins an average of 12.2 weeks after clinical recovery. Acc... Read more
